Circulatory Archives - Page 17 of 25

News
DOAC’s edge over warfarin fades with low adherence
June 12, 2018
BOSTON – When atrial fib patients adhere to a direct oral anticoagulant it outperforms warfarin, but when compliance falls the tables get turned.
News
Skip the catheter-directed thrombolytics
May 30, 2018
Does the addition of catheter-directed thrombolysis to standard therapy with anticoagulation reduce the risk of the postthrombotic syndrome in proximal DVT?
News
LAAC in nonvalvular AF provides stroke protection comparable to warfarin
May 24, 2018
Is mechanical left atrial appendage closure (LAAC) as effective as warfarin at preventing stroke in patients with nonvalvular atrial fibrillation?
News
FDA approves Doptelet for liver disease patients undergoing procedures
May 22, 2018
Avatrombopag (Doptelet) is the first drug approved for thrombocytopenia in adults who have chronic liver disease and are undergoing a procedure.
News
Design limitations may have compromised DVT intervention trial
May 14, 2018
WASHINGTON – The preferred evaluation – intravascular ultrasound – was not used.
News
First reversal agent for apixaban and rivaroxaban gets fast-track approval
May 4, 2018
Andexanet alfa approval puts factor Xa inhibitors in the same ballpark as dabigatran, reversible with idarucizumab.
News
Does warfarin cause acute kidney injury?
May 2, 2018
SAN DIEGO – Consider increased monitoring of renal function in certain patients.
News
Impaired kidney function no problem for dabigatran reversal
April 23, 2018
ORLANDO – Idarucizumab, reversal agent for the anticoagulant dabigatran, worked fine in patients with renal dysfunction.
News
VTE risk after bariatric surgery should be assessed
April 22, 2018
SEATTLE – Thromboelastometry can play a role in identifying bariatric surgery patients at risk for VTE.
News
Common infections are potent risk factor for MI, stroke
April 13, 2018
ORLANDO – Huge U.K. registry identifies a novel cardiovascular risk factor: hospitalization for UTI or respiratory infection.